Rudaka Irina, Vilne Baiba, Isakova Jekaterina, Kalejs Oskars, Gailite Linda, Rots Dmitrijs
Scientific Laboratory of Molecular Genetics, Rīga Stradiņš University, LV-1007 Riga, Latvia.
Latvian Cardiology Centre, Pauls Stradiņš Clinical University Hospital, LV-1002 Riga, Latvia.
J Cardiovasc Dev Dis. 2023 Feb 28;10(3):104. doi: 10.3390/jcdd10030104.
Atrial fibrillation (AF) is the most common arrhythmia and typically occurs in elderly patients with other cardiovascular and extracardiac diseases. However, up to 15% of AF develops without any related risk factors. Recently, the role of genetic factors has been highlighted in this particular form of AF.
The aims of this study were to determine the prevalence of pathogenic variants in early-onset AF in patients without known disease-related risk factors and to identify any structural cardiac abnormalities in these patients.
We conducted exome sequencing and interpretation in 54 risk factor-free early-onset AF patients and further validated our findings in a similar AF patient cohort from the UK Biobank.
Pathogenic/likely pathogenic variants were found in 13/54 (24%) patients. The variants were identified in cardiomyopathy-related and not arrhythmia-related genes. The majority of the identified variants were TTN gene truncating variants (TTNtvs) (9/13 (69%) patients). We also observed two TTNtvs founder variants in the analysed population-c.13696C>T p.(Gln4566Ter) and c.82240C>T p.(Arg27414Ter). Pathogenic/likely pathogenic variants were found in 9/107 (8%) individuals from an independent similar AF patient cohort from the UK Biobank. In correspondence with our Latvian patients, only variants in cardiomyopathy-associated genes were identified. In five (38%) of the thirteen Latvian patients with pathogenic/likely pathogenic variants, dilation of one or both ventricles was identified on a follow-up cardiac magnetic resonance scan.
We observed a high prevalence of pathogenic/likely pathogenic variants in cardiomyopathy-associated genes in patients with risk factor-free early-onset AF. Moreover, our follow-up imaging data indicate that these types of patients are at risk of developing ventricular dilation. Furthermore, we identified two TTNtvs founder variants in our Latvian study population.
心房颤动(AF)是最常见的心律失常,通常发生于患有其他心血管和心外疾病的老年患者中。然而,高达15%的AF发生时没有任何相关危险因素。最近,遗传因素在这种特殊形式的AF中的作用受到了关注。
本研究的目的是确定无已知疾病相关危险因素的早发性AF患者中致病变异的患病率,并识别这些患者中的任何心脏结构异常。
我们对54例无危险因素的早发性AF患者进行了外显子组测序和解读,并在来自英国生物银行的类似AF患者队列中进一步验证了我们的发现。
在13/54(24%)的患者中发现了致病/可能致病的变异。这些变异在与心肌病相关而非心律失常相关的基因中被鉴定出来。大多数已鉴定的变异是TTN基因截短变异(TTNtvs)(9/13(69%)的患者)。我们还在分析的人群中观察到两个TTNtvs始祖变异——c.13696C>T p.(Gln4566Ter)和c.82240C>T p.(Arg27414Ter)。在来自英国生物银行的一个独立的类似AF患者队列的107例个体中,9/107(8%)发现了致病/可能致病的变异。与我们的拉脱维亚患者一致,仅在与心肌病相关的基因中鉴定出变异。在13例有致病/可能致病变异的拉脱维亚患者中,5例(38%)在后续的心脏磁共振扫描中发现一个或两个心室扩张。
我们观察到无危险因素的早发性AF患者中,与心肌病相关基因的致病/可能致病变异患病率很高。此外,我们的随访影像学数据表明,这类患者有发生心室扩张的风险。此外,我们在拉脱维亚研究人群中鉴定出两个TTNtvs始祖变异。